Translational Sciences Inc.
- Biotech or pharma, therapeutic R&D
Translational Sciences has developed highly specific, monoclonal antibodies to improve patient outcomes in cardiovascular disease, bleeding (traumatic or surgical), acute inflammation, etc.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}